Elucid is a medical technology company that has developed a non-invasive image analysis software designed to characterize the biology of cardiovascular disease. Elucid’s patented PlaqueIQ™ technology is the only FDA-cleared and CE-marked analysis software that objectively quantifies plaque morphology validated against tens of thousands of tissue samples and, with an investigational tool, derives FFRCT from these plaque measurements. Advanced clinical insights from Elucid equip physicians with critical information designed to enable precision medicine for both assessing the risk of plaque rupture in arteries that can lead to heart attack and stroke, as well as assessing blockages to determine the need for revascularization.
We will be displaying a new product or promoting a new indication/enhanced feature for an existing product in our booth! Yes
ACC.23 Learning Pathways? (select all that apply) Interventional and Structural Cardiology, Ischemic Heart Disease
First time Exhibitor? Yes